Clinical Trial

Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-05-19; most recent amendment 2025-03-28.
Status change: Not Yet Recruiting → Recruiting 2023-06-26
Trial Details
NCT Number NCT05880537
Lead Sponsor LifeNet Health
Conditions End-Stage Renal Disease
Enrollment 100 participants
Start Date 2023-06-06
Primary Completion 2027-12-15 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-02